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Abstract 
The active sites of metalloenzymes that catalyze O2-dependent reactions generally contain iron or copper ions. 
However, several enzymes are capable of activating O2 at manganese or nickel centers instead, and a handful of 
dioxygenases exhibit activity when substituted with cobalt. This minireview summarizes the catalytic properties 
of oxygenases and oxidases with mononuclear Mn, Co, or Ni active sites, including oxalate-degrading oxidases, 
catechol dioxygenases, and quercetin dioxygenase. In addition, recent developments in the O2 reactivity of 
synthetic Mn, Co, or Ni complexes are described, with an emphasis on the nature of reactive intermediates 
featuring superoxo-, peroxo-, or oxo-ligands. Collectively, the biochemical and synthetic studies discussed herein 
reveal the possibilities and limitations of O2 activation at these three “overlooked” metals. 
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Introduction 
As attested by the articles in this special issue, the on-going tale of O2 activation by metalloenzymes has 
featured two metals as the principal protagonists: iron (both heme and nonheme) and copper. Indeed, our 
fundamental understanding of biological O2 activation has been shaped, in large part, through the study of a 
handful of enzymatic prototypes, such as cytochrome P450, methane monoxygenases, tyrosinase, and the α-
ketoglutarate-dependent dioxygenases. Because of this, it is easy to forget that other transitions metals have 
had distinguished “bit-parts” in this 60-year-old saga. Manganese, cobalt, and nickel are redox-active elements 
that occupy positions adjacent to iron and copper on the periodic table, and all three metals are capable of 
activating O2 in biological environments. For example, many organisms employ manganese-dependent oxidases 
to degrade the toxic metabolite oxalate,1 and a manganese-containing catechol dioxygenase catalyzes a critical 
step in the catabolism of aromatic compounds.2 Certain soil bacteria are able to degrade the compound 
quercetin—a flavonol released into the environment by decomposing plant material—due to a nickel-dependent 
dioxygenase.3 And while no known enzyme requires cobalt to activate O2 in vivo, cobalt-substituted 
dioxygenases generated in vitro have exhibited robust activities that rival the native enzymes.4 
Furthermore, an impressive number of synthetic Mn, Co, and Ni complexes have been reported that harness the 
power of O2 to perform oxidative transformations. Some of these complexes were prepared with biomimetic 
intent, whereas others were generated solely for the purpose of developing novel O2-dependent chemistry. 
Regardless, investigations into the reactivities and spectroscopic properties of these complexes have illuminated 
key features of the relevant enzymes. Synthetic studies have also revealed unique aspects of O2 activation at 
Mn, Co, and Ni sites that suggest alternative “plot lines” that were not pursued in the evolution of metal-
dependent oxygenases. 
The goal of the present minireview is to summarize recent advances in our understanding of O2 activation at 
nonheme mononuclear Mn, Co, and Ni centers in both biological and synthetic contexts (manganese-containing 
ribonucleotide reductases, which feature a dinuclear active site, are treated elsewhere in this special issue). The 
scope of the review is limited to (bio)chemical systems that involve direct reaction of the metal center with O2. 
Thus, we have excluded enzymes that employ reduced O2-derivatives (O 2 ·− , H2O2) as substrates, such as 
catalase (Mn) or superoxide dismutase (Mn, Ni), along with those that operate by substrate activation 
mechanisms (e.g., manganese-containing lipoxygenases, and nickel acireductone dioxygenase). Before delving 
into a discussion of specific enzymes and related models, we will first consider general aspects of the O2 
activation mechanisms commonly employed by these three transition metals, as elucidated through the study of 
synthetic complexes. 
Dioxygen activation pathways for mononuclear Mn, Co, and Ni 
complexes 
Manganese 
As illustrated in Scheme 1, mononuclear Mn sites are capable of supporting an assortment of superoxo-, 
(hydro)peroxo-, and oxo-bound intermediates similar to those observed in heme and nonheme iron enzymes. 
Superoxomanganese(III) complexes are often proposed as the first intermediates formed upon reaction of 
Mn(II) with O2, although well-characterized examples are rare due to generally short lifetimes. By employing 
stopped-flow absorption spectroscopy at reduced temperatures, Kovacs and Rybak-Akimova observed the 
putative superoxomanganese(III) intermediate (complex 1 in Fig. 1) generated by treatment of a five-coordinate 
Mn(II)-thiolate complex with O2.5,6 This species quickly reacts with a second equivalent of Mn(II) to afford a 
dimanganese(III) complex bridged by a trans-μ-1,2-peroxide ligand. Lang et al. succeeded in obtaining a crystal 
structure of a Mn(III) complex (2) featuring a superoxide ligand in an end-on (η1) binding mode (Fig. 1).7 The 
unique stability of 2 is attributed to the steric bulk of the calix4 arene supporting ligand, which prevents 
dimerization. The Mn/O2 unit exhibits an unusual linear geometry (Mn–O–O bond angle of 180°) due to π···π and 
electrostatic interactions between the superoxide anion and NMe 3 + -substituted phenyl rings of the calix4 arene 
“bowl”. The lengthy Mn−O(O) bond of 2.444 Å indicates that the superoxide ligand is only weakly bound to the 
Mn(III) center. 
  
Scheme 1. Dioxygen reactivity of mononuclear Mn species 
  
Fig. 1 Schematic representation (1) and X-ray crystal structure (2) of superoxomanganese complexes prepared 
by the Kovacs5,6 and Lang7 groups, respectively 
Synthetic nonheme Mn(III) complexes with side-on (η2) peroxide ligands—first reported by Kitajima and Moro-
oka in 19948—are generally prepared by treatment of Mn(II) precursors with superoxide or H2O2 (Scheme 1).9,10 
The Borovik group, however, was able to derive a peroxomanganese(III) complex (3; Fig. 2) from direct reaction 
of a Mn(II) complex with O2 in the presence of an H-atom donor, which presumably serves to reduce the 
transient superoxomanganese(III) intermediate.11,12,13 Regardless of the ancillary ligand, η2-peroxomanganese(III) 
complexes are rather unreactive and conversion to a dioxomanganese (V) species has not been achieved. The 
[Mn3+(η2-O2)]+ unit is sufficiently nucleophilic to perform the deformylation of aldehydes (e.g., 
cyclohexanecarboxaldehyde) to produce formate and oxidized products.11,12,14,15,16,17 A recent study of a 
bispidine-supported [Mn3+(η2-O2)]+ complex revealed an alternative deformylation mechanism that involves the 
initial hydrogen-atom transfer from the aldehyde substrate to the peroxide ligand.18 
  
Fig. 2 Peroxomanganese(III) complexes prepared by the Borovik (3)11 and Nam (4 and 5)14,21 groups. The 
coordinates of 4 were obtained from the published crystal structure 
The peroxide bond is also activated by treatment with Lewis acids; for example, addition of Mn(II) has been 
shown to yield bis(μ-oxo-)dimanganese(III,IV) “diamond cores” via O–O bond cleavage.19 Similarly, Jackson and 
coworkers demonstrated that the η2-peroxomanganese(III) complex [Mn(O2)(Me2EBC)]+ decays in the presence 
of Mn(II) starting material to yield a mixture of Mn(IV)-oxo and Mn(III)-OH species (Me2EBC = 4,11-dimethyl-
1,4,8,11-tetraaza-bicyclo[6.6.2]hexadecane)20 Recently, Nam et al. trapped an end-on manganese(III)-
hydroperoxide intermediate (5) via addition of acid to [Mn(η2-O2)(14-TMC)]+ (4),14 where 14-TMC = 1,4,8,11-
tetramethyl-1,4,8,11-tetraazacyclotetradecane (Fig. 2).21 Reactivity studies indicated that protonation enhances 
the ability of the manganese peroxide moiety to perform electrophilic chemistry, such as oxygen atom transfer 
(OAT) reactions. 
The long-standing interest in high-valent oxomanganese species arises, in large part, from their relevance to 
putative intermediates in the oxygen-evolving mechanism of photosystem II. An impressive number of binuclear 
Mn(IV)2 and Mn(III)Mn(IV) complexes with μ-oxide ligands have been reported, and some were prepared via 
aerobic oxidation of Mn(II) precursors.22,23,24,25,26 This reaction likely occurs by the initial formation of a 
dimanganese(III)-peroxide intermediate, followed by O–O bond cleavage (Scheme 1). Interestingly, synthetic 
chemists have yet to trap a mononuclear Mn(IV)-oxocomplex using O2 as the sole oxidant. Nearly, all of the 
currently available oxomanganese complexes, such as 6 in Fig. 3, were prepared by treating Mn(II) precursors 
with O-atom transfer reagents, such as iodosylbenezene (PhIO), peroxy acids, or H2O2.27,28,29,30,31,32 Borovik and 
coworkers, however, have developed an alternative route to mononuclear high-valent oxomanganese 
complexes. Using a tripodal ligand capable of stabilizing terminal oxometal units through multiple H-bonding 
interactions (Fig. 3), a monomeric oxomanganese(III) complex (7) was generated via reaction with O2.33 Stepwise 
oxidation of this complex by ferrocenium yielded Mn(IV)-oxo and Mn(V)-oxo derivatives (8 and 9, respectively), 
as confirmed by EPR spectroscopy and DFT calculations.34,35,36 
  
Fig. 3 Schematic representations of oxomanganese complexes 6–927,33,34,35,36 
Two mononuclear Mn(V)-oxo species have been generated by aerobic oxidation of Mn(III) complexes bearing 
highly anionic, square-planar macrocycles similar to porphyrins. The corrolazine-based oxomanganese(V) 
complex of Goldberg was prepared by a free-radical mechanism initiated by photoactivation of the Mn(III) 
precursor in the presence of O2.37,38 The tetraamido-based oxomanganese(V) complex of Nam and Fukuzumi is 
proposed to arise from homolytic O–O cleavage of a manganese(IV) (hydro)peroxide intermediate formed after 
O2 binding to Mn(III).39 While notable, these mechanisms differ from manganese-based O2 activation at 
nonheme sites in nature, which begin by reaction of O2 with Mn(II) centers. 
Cobalt 
The O2-activation landscape of cobalt is summarized in Scheme 2. The ability of square-planar Co(II) complexes 
featuring porphyrin, phthalocyanine, tetrazamacrocyclic, and Schiff-base (e.g., salen) ligands to reversibly bind 
O2 has been studied extensively for decades, and the findings are described in several helpful reviews.40,41,42,43 
These Co/O2 adducts, which consist of a low-spin Co(III) center bound to a η1-superoxide ligand (10 in Fig. 4), 
have often served as models of Fe/O2 species in dioxygen carrier proteins; yet the former exhibits greater 
stability, on average, due to the kinetic inertness of Co(III). In addition, numerous Co(II)-salen catalysts have 
been developed for the aerobic oxidation of phenols and olefins.44,45,46,47,48 The key step in the catalytic cycle 
generally involves H-atom transfer (HAT) from a weak O–H or C–H bond to the cobalt(III)-bound superoxide 
ligand, thereby initiating a radical-based oxidation mechanism.49,50 When supported by neutral amine-based 
ligands, mononuclear superoxocobalt(III) intermediates are usually not observed due to fast reaction with a 
second Co center, thereby yielding dicobalt(III) complexes with μ-1,2-(su)peroxide ligands.51,52,53,54 
  
Scheme 2 Dioxygen reactivity of mononuclear Co species 
  
Fig. 4 X-ray crystal structures of superoxocobalt complexes 10 and 1155,56 
In 1990, Theopold and coworkers reported the crystal structure of a mononuclear cobalt(II) complex (11) 
featuring a side-on (η2) superoxide ligand.55 The complex was prepared via oxidative addition of O2 to a low-
valent cobalt(I) center supported by the hydrotris(3-tert-butyl-5-methyl-pyrazolyl)borate (TptBu,Me) ligand (Fig. 4). 
When a less sterically bulky Tp ligand was employed, the [Co(η2-O2)] adduct dimerized at low temperatures to 
yield a dicobalt(II) complex with two trans-μ-η1:η1 superoxide ligands (Scheme 2).57 The O–O bond lengths 
measured by X-ray crystallography for these Tp-based complexes range between 1.26 and 1.36 Å, suggesting 
that the putative Co(II)-superoxo-units possess partial Co(III)-peroxide character. In certain cases, treatment of 
the mononuclear [Co(η2-O2)(Tp)] adduct with a second Co(I) equivalent yielded a dicobalt(III) bis(μ-oxo) species, 
which likely arises from O–O homolysis of a dicobalt(II) μ-η2:η2-peroxide intermediate.58,59 Other structurally 
characterized [Co2(μ-O)2]2+ complexes derived from reaction with O2 have featured bidentate β-diketiminato,60 
guanidinato,61 or monodeprotonated ureayl ligands.62 Hikichi et al. have shown that dicobalt(III) bis(μ-oxo) 
intermediates are potent oxidants capable of hydroxylating the isopropyl substituents of the Tp ligand.59,63,64 
Mononuclear peroxocobalt(III) complexes have been prepared by one of two routes: (1) direct reaction of Co(I) 
centers with O2 or (2) treatment of Co(II) precursors with H2O2 under basic conditions. Meyer et al. used the 
former approach to prepare [Co(O2)(TIMENxyl)]+ (12; Fig. 5), where TIMENxyl is a tripodal N-heterocyclic carbene 
ligand.65,66 The strong σ-donating ability of the carbene groups favors a peroxocobalt(III) configuration over the 
superoxocobalt(II) alternative adopted by Tp-based complexes. Nam and coworkers followed the H2O2/NEt3 
route to prepare complexes, such as complex 13 in Fig. 5, featuring X-TMC macrocycles of varying sizes (X = 12, 
13, 14, or 15, where X is the number of atoms in the cyclam ring).67,68 In all structurally characterized examples, 
the peroxide ligand coordinates to Co(III) in a side-on (η2) fashion with an O–O bond distance of ~1.43 Å. The η2-
peroxocobalt(III) complexes are sluggish oxidants with limited ability to perform hydroxylation, HAT, or OAT 
reactions; however, they are competent to perform oxidative nucleophilic reactions with aldehydes.67,68,69 Nam 
et al. have shown that treatment of [Co(η2-O2)]+ complexes with acids provides a spectroscopically observable 
cobalt(III)-hydroperoxide species capable of both electrophilic and nucleophilic oxidation reactions.68,70 When 
the 15-TMC ligand is employed, decay of the cobalt(III)-hydroperoxide species is accompanied by hydroxylation 
of the methyl group of the TMC ligand.68 Mechanistic evidence suggests that the hydroxylation is performed by a 
short-lived oxocobalt(IV) or oxylcobalt(III) intermediate (not observed) arising from O–O bond homolysis 
(Scheme 2). 
  
Fig. 5 X-ray crystal structures of η2-peroxocobalt(III) complexes prepared by the Meyer (12)65,66 and Nam (13)67 
groups 
Although cobalt complexes with terminal oxoligands are frequently invoked as transient intermediates in the 
decay of cobalt-(alkyl/hydro)peroxide species, attempts to isolate such an entity have not been successful to 
date.55,57,58,59,71,72,73,74 This shortcoming is not surprising given the intrinsic instability of terminal oxometal 
complexes of groups 9–11 (often referred to as the “oxowall” for tetragonal structures).75 The nearest analogs of 
these elusive species are a handful of mononuclear Co(III) and Co(IV) complexes featuring [Co−O−M] units, 
where M is a redox-inactive metal ion like Sc(III). For example, Ray and coworkers found that treatment of 
[Co2+(TMG3tren)(OTf)]+ with a derivative of PhIO triggers hydroxylation of the tripodal TMG3tren supporting 
ligand (TMG3tren = tris[2-(N-tetramethyguanidyl)ethyl]amine).76 The oxocobalt species (14) in Fig. 6 was trapped 
by addition of Sc3+ at low temperatures. Data gathered using EPR and X-ray absorption spectroscopies suggested 
that 14 features a [Co4+(μ-O)Sc3+] core with an S = 3/2 ground state, although [Co3+(μ-O•)Sc3+] and [Co3+(μ-
OH)Sc3+] assignments have also been proposed.73,77 Using a similar approach, Ray and Nam generated a series of 
S = 1/2 [Co4+(μ-O)Mn+] complexes (15 M ; M = Sc3+, Y3+, Ce3+, Zn2+) via reaction of PhIO with the square-planar 
[Co3+(TAML)]− complex (TAML = tetraamido macrocyclic ligand) in the presence of redox-inactive metal ions 
(Fig. 6).78 The 15 M complexes are capable of performing both HAT and OAT reactions, with reactivity increasing 
with the Lewis acidity of the redox-inactive metal ion. 
  
Fig. 6 Schematic representations of putative oxocobalt complexes prepared by Ray and coworkers76,78 
Nickel 
Nickel(II) complexes are generally unreactive towards O2 unless electron-rich ligands are employed to depress 
the Ni2+/3+ redox potential. For example, Kimura and Martell reported a series of nickel(II) complexes with 
dioxopentaaza macrocyclic ligands capable of catalyzing oxygen insertion reactions under aerobic 
conditions.79,80,81 Although never isolated, superoxonickel(III) species were proposed as the active intermediates 
in the oxygenation mechanisms. Nickel(II)-thiolate complexes are also known to react with O2 to afford the 
corresponding metallosulfoxides and metallosulfones. Mechanistic evidence suggests that these reactions 
involve direct reaction of O2 with the thiolate ligand without oxidation of the nickel(II) center.82 
Much of the nickel-dioxygen chemistry reported in the past 15 years has harnessed the enhanced O2 reactivity 
of electron-rich Ni(I) precursors. In 2001, Riordan described the synthesis of a dinickel(III) bis(μ-oxo) complex 
(16; Fig. 7) from the reaction of O2 with [Ni+(CO)(PhTt tBu)], where PhTt tBu = phenyltris((tert-
butylthio)methyl)borate.83,84,85 Resonance Raman (rR) and X-ray absorption spectroscopies affirmed the 
presence of the [Ni 2 3+ (μ-O)2] core.86 The formation of 16 was presumed to follow the conventional 
superoxo→peroxo→bis(μ-oxo) pathway involving the initial formation of a 1:1 Ni:O2 adduct, followed by 
reaction with a second Ni(I) equivalent and O–O bond homolysis. In support of this mechanism, a monomeric η 
2-superoxonickel(II) species (17; Fig. 7) was obtained by reaction of O2 with [Ni+(CO)(PhTtAd)], which features 
bulky adamantyl (Ad) groups on the PhTt supporting ligand to prevent dinucleation.87 Treatment of 17 with 
[Ni+(CO)(PhTt tBu)] afforded the asymmetric dimer, [(PhTtAd)Ni3+(μ-O)2Ni3+(PhTt tBu)]. 
  
Fig. 7 Left Schematic representations of η 2-superoxonickel(II) and dinickel(III) bis(μ-oxo) complexes (17 and 16, 
respectively) prepared by Riordan and coworkers.83,87 Right X-ray crystal structures of complexes 18 and 19 
generated by Driess et al. The 18-crown-6 ether in the structure of 19 was omitted for clarity88,90 
More recently, Driess et al. reported the crystal structure of a square-planar η2-superoxonickel(II) complex (18; 
Fig. 7) bearing a β-diketiminato ligand prepared by reaction of a Ni(I) precursor with O2.88,89 The observed O–O 
bond distance of 1.35 Å is characteristic of a superoxide ligand. One-electron reduction of 18 using elemental 
potassium provided an unusual structure (19) in which a μ-η2:η2-peroxide ligand with an O–O bond distance of 
1.47 Å serves as a bridge between the nickel(II) center and a potassium ion solvated by 18-crown-6 ether.90 
Reaction of 18 with a Cu(I) complex was shown to trigger O–O bond cleavage leading to formation of a 
heterobimetallic [Cu3+(μ-O)2Ni3+] core.91 
The N-tetramethylcyclam (TMC) framework is capable of supporting both superoxonickel(II) and 
peroxonickel(III) units, depending on the size of the TMC ring. End-on (η1) superoxonickel(II) complexes have 
been synthesized using 13-TMC and 14-TMC.92,93 Riordan and coworkers observed that oxygenation of [Ni+(14-
TMC)]+ at low temperature generates a metastable dinickel(II) species (20; Fig. 8) with a bridging μ-1,2-peroxide 
ligand, as determined by rR and DFT analyses.94,95 Under conditions of excess O2, the mononuclear complex 
[Ni2+(η1-O2)(14-TMC)]+ (21) is the dominant product.92 The same complex was also prepared by addition of 
excess H2O2 and NEt3 to [Ni2+(14-TMC)]2+. Remarkably, reaction of [Ni2+(12-TMC)]2+ with the same H2O2/NEt3 
combination yielded a η2-peroxonickel(III) complex instead of the expected η1-superoxonickel(II) species, 
highlighting the ability of TMC ancillary ligands to modulate the geometric and electronic structures of 
mononuclear [NiO2]+ intermediates.10,96 Nam and others have shown that [Ni3+(η2-peroxo)]+ complexes, like their 
Mn and Co congeners, perform the nucleophilic deformylation of aldehydes.96,97 By contrast, end-on and side-on 
superoxonickel(II) complexes are electrophilic and participate in OAT reactions with triphenylphosphine.93 
  
Fig. 8 Peroxodinickel(II) (20) and η1-superoxonickel(II) (21) species obtained using the [Ni(14-TMC)]2+/+ 
framework92,95 
The only crystallographically characterized example of a nickel-hydroperoxide complex was recently reported by 
Gade and coworkers. These researchers found that reaction of O2 with a pincer-based Ni(I) complex (Fig. 9) 
yielded a η1-superoxonickel(II) complex (22) that exists in equilibrium with its dinickel(II) μ-1,2-peroxo-bridged 
counterpart (23).98 Treatment of the latter with H2O2 provided complex 24 and the resulting crystal structure 
revealed a square-planar Ni(II) center bound to an end-on hydroperoxide donor. Aerobic decomposition of 24 is 
accompanied by autoxidation of the pincer ligand to yield a novel alkylperoxo-metallacyclic complex.99 
  
Fig. 9 Series of superoxo-, peroxo-, and hydroperoxo-nickel(II) complexes generated by Gade et al. using a chiral 
pincer ligand98 
The same factors that make it challenging to isolate mononuclear oxocobalt species (vide supra) have also 
prevented, at least so far, definitive characterization of a nickel complex featuring a terminal oxoligand. 
Transient oxo/oxyl nickel species are likely involved in alkane hydroxylation reactions catalyzed by Ni(II) 
complexes in the presence of the oxidant m-chloroperbenzoic acid (mCPBA).100,101 The proposed catalytic 
mechanism involves the initial formation of an acylperoxo-nickel(II) species, followed by O–O bond homolysis to 
yield the active oxo-nickel(III) or oxylnickel(II) intermediate. Ray and coworkers have succeeded in trapping a 
metastable complex (25) that arises from oxidation of [Ni2+(TMG3tren)(OTf)2] with mCPBA at −30 °C.102 Data 
gathered using EPR and UV–vis spectroscopies indicate that this species consists of a Ni(III) center bound to a 
terminal oxo- or hydroxo-ligand, although a conclusive structural determination was not possible due to its 
instability and low yield of formation (~15 %). Company et al. followed a similar procedure to generate a 
putative oxylnickel(III) species (26) supported by a tetradentate bisamidate ligand.103,104 Analysis with X-ray 
absorption spectroscopy (XAS) revealed a nickel–oxygen distance of 1.88 Å, and the preponderance of 
spectroscopic and computational data favored an oxylnickel(III) configuration rather than the oxonickel(IV) 
alternative. While these results are certainly promising, the assignment of 26 as an oxylnickel(III) species 
remains tentative and additional characterization with structural and spectroscopic methods is required to 
confirm this hypothesis (Fig. 10). 
  
Fig. 10 Schematic representations of putative nickel(III) complexes with hydroxo/oxo (25) or oxyl (26) 
ligands102,103,104 
Dioxygen activation at mononuclear Mn, Co, and Ni enzymes and 
model complexes 
Manganese oxalate-degrading enzymes 
The accumulation of oxalic acid—a byproduct of metabolic pathways in plants, fungi, and microbes—has 
harmful consequences for nearly all organisms. To mitigate the toxic effects of this organic acid, nature has 
evolved two classes of manganese-dependent enzymes that degrade oxalate via different reactions.1,105,106 
Oxalate oxidase (OxOx) catalyzes the oxidation of oxalate to two moles of CO2 (Eq. 1). Dioxygen serves as the 
electron and proton acceptor in this process, resulting in concomitant formation of H2O2. In contrast, oxalate 
decarboxylase (OxDC) catalyzes the conversion of oxalate to formate and CO2 (Eq. 2). Even though the OxDC 
reaction is merely a disproportionation, the enzyme requires both manganese and O2 for activity.107 The OxOx 
family plays the dominant role in oxalate catabolism in plants.108 whereas the OxDC family is more common in 
fungi and bacteria.1 Humans lack these oxalate-degrading enzymes and thus excessive amounts of dietary 
oxalate (hyperoxaluria) can lead to formation of calcium oxalate stones in the kidney.109 
  
Both OxOx and OxDC belong to the functionally diverse superfamily of cupin proteins, and the close structural 
and sequence similarities between the two enzymes point to a common evolutionary ancestor.110,111 A high-
resolution X-ray crystal structure published in 2000 revealed that barley OxOx is a homohexamer in which each 
monomer contains one manganese ion within its jellyroll β-barrel domain.112 Crystal structures of bacterial 
OxDC’s from Bacillus subtilis display a similar homohexameric arrangement.113,114 However, each OxDC subunit 
consists of two cupin domains and, therefore, possesses two nearly identical manganese-binding sites, 
suggesting that OxDC might have arisen from gene duplication of OxOx.113 Based on structural and mutagenesis 
studies, it appears that catalytic activity largely occurs at the N-terminal site, while the role of the C-terminal site 
remains ambiguous.114,115,116,117 The active sites of OxOx and OxDC both feature a six-coordinate manganese(II) 
center bound to one glutamate and three histidine side chains, in addition to two water molecules in a cis 
arrangement (Fig. 11).112,113 
  
Fig. 11 Manganese active site of OxOx from Hordeum vulgare (barley).112 PDB 1FI2 
The catalytic cycles of OxOx and OxDC are initiated by coordination of oxalate to the Mn(II) center, displacing 
one or both of the H2O molecules found in the resting state. It is generally assumed that oxalate binds in a 
monodentate fashion, and this hypothesis is supported by crystal structures of OxOx featuring the substrate-
analog glycolate118 and a cobalt-substituted OxDC/oxalate complex.119 Oxalate coordination serves to lower the 
Mn3+/2+ redox potential, thus facilitating formation of a Mn/O2 adduct with η1-superoxomanganese(III) 
character.120 In the OxOx/OxDC mechanisms favored by both Richards and Bornemann, O2 binding is followed by 
a key proton-coupled electron transfer (PCET) step involving deprotonation of the oxalate ligand and transfer of 
an electron from oxalate to the nascent Mn(III) center (Scheme 3).114,121,122 The end-result is a putative 
superoxomanganese(II)-(oxalate radical anion) intermediate common to both OxOx and OxDC. Because one-
electron oxidation of oxalate dramatically weakens its C–C bond.123 this intermediate undergoes spontaneous 
decarboxylation to generate CO2 and a manganese-bound formyl radical anion. At this point, the mechanisms of 
OxOx and OxDC diverge. The formyl radical either couples with the superoxo-ligand to yield a manganese(II)-
peroxycarbonate species (OxOx) or undergoes protonation by a conserved second-sphere Glu162 residue to 
afford a manganese(III)-formate intermediate (OxDC).114,121,122 In support of this proposal, Bornemann and 
coworkers demonstrated that B. subtilis OxDC can be converted into an oxidase by mutating four residues 
(including Glu162) in the flexible lid of the N-terminal site.124 Furthermore, radical-trapping EPR experiments 
have confirmed the presence of superoxo- and oxalate-derived radicals during catalysis.124,125,126 and the OxDC 
mechanism shown in Scheme 3 is consistent with heavy-atom isotope effect measurements.122,127 
  
Scheme 3 Proposed catalytic mechanisms for OxOx and OxDC 
The publication of the enzymatic structures has stimulated the development of synthetic models of the OxOx 
and OxDC active sites. In 2005, Berreau and coworkers prepared a mononuclear Mn(II) complex (27) with a N3O 
donor set provided by the chelate bpppa (Fig. 12), in which the oxygen donor is provided by the 2-amido 
substituent of one of the pyridine rings.128 Attempts to generate the oxalate-bound form of 27 afforded a 
dimanganese(II) complex, [Mn2+(μ2-oxalate)(bpppa)2]2+, that features a bridging oxalate dianion. Subsequently, 
Berreau et al. generated a series of [Mn2+(N3O)(X)(MeOH)]+ complexes (X = Cl−, Br−, I−) using bpppa and a related 
derivative to mimic the 3His/1Glu coordination of the enzymes.129 No reactivity studies with O2 were reported. 
The Pecoraro and Chavez groups have both prepared structural models of the resting active sites using 1,4,7-
triazacyclononane (TACN) ligands with pendant acetate groups.130,131 Chavez found that complex 28 (Fig. 12) 
binds oxalate in solution and exposure to O2 results in catalytic decomposition of oxalate to CO2 (2 equiv. of CO2 
per oxalate ion). However, further analysis found that the catalytically active species is likely [Mn3+(oxalate)2]−, 
not complex 28.130 
  
Fig. 12 X-ray crystal structure (27) and schematic representation (28) of synthetic models of the OxOx/OxDC 
active sites128,130 
Extradiol catechol dioxygenases 
The aerobic degradation of biomolecules by soil bacteria requires a variety of metal-containing dioxygenases 
that incorporate both atoms of O2 into the product.132,133,134 Extradiol catechol dioxygenases (ECDOs) catalyze 
the oxidative scission of the C–C bond adjacent to the vicinal dihydroxy unit of catechol-containing substrates, as 
shown in Eq. 3.135,136 While the majority of ECDOs feature a mononuclear iron(II) active site, 
homoprotocatechuate-2,3-dioxygenases (HPCDs) from Bacillus brevis137 and Arthrobacter globiformis (Mn-
MndD)138 contain a manganese(II) center instead. Iron-containing HPCD (Fe-HPCD) and Mn-MndD exhibit 83 % 
sequence identity and crystallographic studies revealed that the active-site structures are nearly superimposable 
to beyond 15 Å from the metal centers.139,140 In the resting states of both enzymes, the divalent metal ion is 
bound to one glutamate and two histidine residues in a facial geometry (the so-called 2-His-1-carboxylate facial 
triad141); three labile H2O ligands complete the metal coordination sphere.  
  
Regardless of the active-site metal, all ECDOs are thought to follow a common mechanism (Scheme 4) that has 
been elucidated through a combination of crystallographic, spectroscopic, kinetic, and computational 
studies.132,142,143,144 The catalytic cycle begins with displacement of the H2O molecules by the monodeprotonated 
substrate, which coordinates in a bidentate fashion. The resulting M(II) center is then capable of binding O2 in 
the vacant site adjacent to the bound substrate. On the basis of experimental and computational evidence, it 
has been proposed that formation of the M/O2 adduct is coupled to oxidation of the bound substrate, yielding a 
superoxo-M(II)-semiquinone (SQ) species (Scheme 4).145,146,147,148,149,150,151 Studies of relevant model complexes 
have confirmed that such an intermediate is feasible due to the “noninnocent” nature of dioxolene 
ligands.152,153,154,155,156,157 However, spectroscopic studies of Fe-HPCD employing mutant enzyme and/or 
unactivated substrate have failed to detect a catalytically viable Fe(II)/SQ species,158,159,160 and a recent density 
functional theory (DFT) analysis of the iron-based mechanism favored a superoxo-Fe(III)-catecholate description 
instead.161 Thus, the precise electronic structure of the M/O2 adduct remains a matter of dispute, and we will 
return to this topic below. Nevertheless, it is clear that the next step in the catalytic cycle involves formation of a 
metal(II)-alkylperoxide intermediate, followed by Criegee rearrangement with ring insertion of an oxygen atom. 
Hydrolysis of the resulting lactone finally yields the aliphatic product (Scheme 4). 
  
Scheme 4 Proposed catalytic mechanism for extradiol catechol dioxygenase 
During the past decade, important insights into the O2 activation mechanism of ECDOs have been gained 
through the preparation of enzymes reconstituted with a nonphysiological metal in the active site. Since these 
studies were the subject of a recent review article published in this journal,4 we will provide only a cursory 
overview of the major findings here. In a seminal 2008 paper, the Que and Lipscomb groups described a 
methodology for “swapping” the metal ions Fe-HPCD and Mn-MndD, thereby generating manganese-
substituted HPCD (Mn-HPCD) and iron-substituted MndD (Fe-MndD).140 Subsequent efforts by the same groups 
yielded cobalt-substituted HPCD (Co-HPCD).162 Comparison of HPCD crystal structures collected for the wild-type 
(WT) and metal-substituted enzymes revealed that the active-site structures are identical regardless of the 
metal ion present (Mn, Fe, or Co).140,162 Kinetic measurements determined that the steady-state catalytic 
parameters for the four Fe- and Mn-containing enzymes (Fe-HPCD, Mn-MndD, Fe-MndD, and Mn-HPCD) were 
quite similar, indicating that metal-substitution has little effect on enzyme activity.140 This result is surprising, 
because the Mn3+/2+ redox potential is intrinsically higher than the Fe3+/2+ potential by approximately 0.7 V,163 
and the identical first and second coordination spheres of HPCD and MndD preclude the possibility of redox 
tuning by the active site. If the mechanism required one-electron transfer from the M(II) ion to O2, one would 
expect Mn-HPCD and Mn-MndD to be less active than their iron-containing counterparts, not equally active. To 
rationalize this apparent inconsistency, the authors argued that the ECDO mechanism does not, in fact, require a 
well-defined change in metal oxidation state upon O2 binding; instead, the metal ion merely serves to shuttle an 
electron from the catecholate substrate to O2, giving rise to the elusive O 2 ·− /M(II)/SQ intermediate in a 
concerted step.140,164 
The metal-substituted HPCDs have been utilized in attempts to trap and characterize reactive intermediates. The 
reaction of Mn-HPCD with O2 generates two short-lived intermediates that were observed by EPR spectroscopy 
in samples prepared via rapid freeze-quench experiments.165 EPR analysis indicated that the first-formed species 
(Int1) consists of a Mn(III) center bound to an unidentified radical, perhaps superoxide or semiquinone. The 
later-forming intermediate (Int2) is an Mn(II) species and was assigned to the alkylperoxide intermediate in 
Scheme 4. These results would seem to contradict the theory, described above, that the oxidation state of the 
metal center does not change during ECDO catalysis. However, the low yield of Int1 (5 %) and a lack of structural 
information make it difficult to draw firm mechanistic conclusions. 
The kinetic parameters measured for Co-HPCD differ from those reported for Fe- and Mn-HPCD in ways that are 
informative. The Co3+/2+ redox potential is predicted to be ~ 1.15 V higher than the Fe3+/2+ potential for ions in the 
same coordination environment, which accounts for the very low affinity of Co-HPCD for O2 under turnover 
conditions (K M O2  = 1200 μM, compared with ~50 μM for Fe- and Mn-HPCD).162 However, this diminished O2 
affinity is partially offset by a larger k cat-value for Co-HPCD under conditions of O2 saturation; indeed, k cat is 
highly dependent on the solution concentration of O2. Taken together, these results suggest that the rate-
determining step is O2-binding/activation for Co-HPCD, whereas product release is known to be rate-limiting for 
Fe-HPCD. A possible explanation for these mechanistic differences became apparent in EPR studies of Co-HPCD 
using an electron-poor substrate, 4-nitrocatechol (4NC).166 While the Co-HPCD/4NC complex features a high-spin 
(S = 3/2) Co(II) center, exposure to O2 affords a low-spin (S = 1/2) signal characteristic of a superoxocobalt(III) 
species. This spin-state change may impose a kinetic barrier to O2 binding in Co-HPCD that is not present in Fe- 
and Mn-HPCD, where the metal ions remain high-spin throughout the catalytic cycle. A superoxocobalt(III) 
species is not observed when the native substrate is employed. It was proposed that the more activated 
substrate rapidly transfers an electron to the Co(III) center to yield a putative high-spin O 2 ·− /Co(II)/SQ 
species.166 This hypothesis found support in a recent QM/MM study of the Co-HPCD mechanism by Lai and 
coworkers.167 
By studying both wild-type and metal-substituted enzymes with a variety of experimental and computational 
methods, a largely consistent picture of O2 activation in ECDOs has emerged. The broad similarities in catalysis 
between Mn-, Fe-, and Co-HPCD, despite the vastly different redox potentials of the respective metal ions, 
clearly indicate that O2 binding requires a significant amount of electron transfer from the catecholate substrate, 
although partial or transient oxidation of the metal centers may also be involved.4 On-going efforts to trap and 
characterize catalytic intermediates will likely provide additional insights into the mechanisms of these finely-
tuned enzymes. 
Attempts to generate structural and functional models of the manganese-dependent ECDOs have been rather 
limited, lagging far behind biomimetic studies of iron-containing ring-cleaving dioxygenases.132,168,169 Que and 
coworkers used neutral, tetradentate N4 chelates to prepare six-coordinate Mn-MndD models featuring a 
monoanionic 4-nitrocatecholate ligand, yet O2 reactivity experiments were not pursued.170 Other ECDO models 
have been generated by binding dianionic catecholate ligands to Mn(III) centers.171,172,173,174,175,176 The resulting 
complexes often exhibit valence tautomerization between Mn(III)-catecholate and Mn(II)-semiquinone 
configurations (Fig. 13), where the latter resembles the O 2 ·− /Mn(II)/SQ species proposed for the enzymatic 
mechanism. Several groups have demonstrated that six-coordinate Mn(II)/SQ complexes serve as intermediates 
in the catalytic oxidation of catechols to benzoquinones under aerobic conditions (i.e., catechol oxidase 
activity).171,172,173 Hikichi and coworkers also observed small amounts of intradiol and extradiol ring-cleavage 
products upon reaction of the five-coordinate complex [Mn2+(DTBSQ)(TpiPr2)] (29; Fig. 13) with O2 (DTBSQ = 3,5-
di-tert-butylsemiquinonate).176 
  
Fig. 13 Synthetic models of extradiol catechol dioxygenases containing manganese (top)176 and cobalt 
(bottom)179 
Cobalt dioxolene complexes have attracted considerable scrutiny due to their valence tautomeric behavior,177 
yet the O2 reactivity of such complexes has not been examined until recently. In an extension of their 
manganese studies, Hikichi et al. found that [Co2+(DTBSQ)(Tp Me2)] serves as a catalyst for the aerobic oxidation 
of ortho- and para-hydroquinones with simultaneous formation of H2O2.178 More recently, Riordan and 
coworkers reported that the five-coordinate complex [Co2+(DTBSQ)(PhTt tBu)] (30; Fig. 13) reacts with O2 to afford 
the intradiol cleavage product in 16 % yield.179 
Quercetin dioxygenases 
The aerobic breakdown of plant-derived flavonols by fungi and some bacteria is an important process in soil 
environments.180,181 The first step in the catabolism of quercetin (3,5,7,3′,4′-pentahydroxyflavone) involves 
dioxygenolytic cleavage of the 3-hydroxyflavone ring to yield a depside product and carbon monoxide (Eq. 4). 
This reaction is catalyzed by quercetin dioxygenases (QDOs), which belong to the cupin superfamily of 
enzymes.182 The best-studied QDOs have been isolated from fungi and require copper for activity. 
Crystallographic studies revealed that the active site of fungal QDO from Aspergillus japonicus (QDOAj) features a 
mononuclear Cu(II) center bound to the three His residues and one water molecule.183 In contrast, an X-ray 
structure of bacterial QDO from Bacillus subtilis (QDOBs) featured two monoiron(II) active sites per subunit.184 
Both iron centers are pentacoordinate with four protein ligands (one Glu and three facial His) and one H2O 
ligand (Fig. 14). However, in the site closest to the C-terminus, the Glu ligand is only weakly bound with an Fe–
OGlu distance of 2.44 Å. While QDOBs is thought to be an iron-containing dioxygenase in vivo, it exhibits equal or 
greater activity with other transition-metal ions, including Mn, Co, Ni, and Cu.184 The QDO from Streptomyces sp. 
strain FLA (QDOFLA) is similarly “promiscuous”, displaying catalytic activity following the order Ni > Co > Mn 
(strangely, QDOFLA is inactive with ferrous iron).3,185 Crystallographic studies indicate that the active sites of 
QDOBs (Fe) and QDOFLA (Ni) provide similar metal coordination environments regardless of metal ion 
identity.184,186 Structures of the enzyme-substrate complexes revealed that the deprotonated substrate 
coordinates in a monodentate manner via the O3 atom.183,186 
  
  
Fig. 14 X-ray crystal structures of the substrate-bound active site of QDOFLA (left) and complex 31 (right) 
The precise role of the metal center in the O2 activation mechanism of QDOs has been the subject of much 
debate.187 The fact that QDO activity is largely independent of the redox potential of the active-site metal makes 
it unlikely that the catalytic cycle involves electron transfer from the M(II) center to O2. Moreover, flavonolate 
anions are known to react with O2 to yield QDO-type products in the absence of redox-active ions, leading some 
to suggest that the metal ion does not bind O2 at all and simply serves to deprotonate the substrate.188 As shown 
in Scheme 5a, such a mechanism could proceed via direct addition of O2 to the flavonolate ring, or outer-sphere 
electron transfer to yield superoxide and substrate radicals. In either case, the resulting cyclic peroxide species 
would decompose via concerted O–C and O–O bond cleavages, affording the depside and CO products. Recently, 
however, Dobbek and coworkers reported strong evidence in favor of a metal-based O2 activation mechanism. 
After exposing crystals of the substrate-bound enzyme to O2 for short periods of time, the resulting X-ray 
structure revealed the presence of a Ni/O2 adduct in the QDOFLA active site.186 The O2 ligand is coordinated in a 
side-on fashion with Ni–O and O–O bond distances of 2.4 and 1.3 Å, respectively. Based on their results, Dobbek 
et al. proposed the ECDO-like mechanism shown in Scheme 5b, in which O2 binding yields a superoxo-Ni(II)-
(flavonol radical) intermediate, followed by O–C bond formation. A similar mechanism was derived from DFT 
studies performed by Siegbahn.189 While it is possible that the crystallographically observed Ni/O2 is not 
catalytically relevant, this study provides unambiguous proof that O2 is capable of coordinating to the metal 
center of a QDO. 
  
Scheme 5 Two possible catalytic mechanisms for quercetin dioxygenase 
The majority of QDO model complexes prepared to date contain copper-flavonolate units, and these efforts 
have been reviewed by Kaizer et al.190 In light of the ability of QDOs to operate with non-native metals, several 
groups have prepared metal(II)-flavonolate complexes using other first-row transition metals.191,192,193,194,195,196 In 
the past few years, Sun and coworkers have reported a series of QDO models (M = Mn, Fe, Co, Ni, Cu, and Zn) 
supported by a tetradentate N3O chelate featuring a benzoate donor which closely resembles the enzymatic 
coordination environments (see complex 31 in Fig. 14).197,198,199,200 Unlike the enzyme, however, the flavonolate 
ligands in Sun’s models coordinate in a bidentate manner to afford six-coordinate structures. While reaction 
rates vary with metal ion, each of these complexes reacts with O2 at elevated temperatures to yield CO and 
oxidized ring-cleavage products. Berreau and coworkers also demonstrated that irradiation of metal(II)-
flavonolate complexes (M = Mn, Co, Ni, Cu) in the presence of O2 triggers QDO-like reactivity.195 
There are numerous similarities between QDOs and nickel-containing acireductone dioxygenase (Ni-ARD) which 
catalyzes an “exit reaction” from the methionine salvage pathway (Scheme 6).187,201,202,203 Both enzymes 
generate CO as a product and contain mononuclear active sites featuring 3His/1Glu coordination of a divalent 
metal ion.204 Like QDO, Ni-ARD exhibits nearly full activity with non-native metal ions, such as Co(II) and 
Mn(II).204,205 Even more remarkably, an iron-containing ARD (Fe-ARD) is also involved in the methionine salvage 
pathway, yet the iron and nickel enzymes catalyze different dioxygenation reactions with the same substrate 
(Scheme 6).205 However, the metal ions of both ARD enzymes are not redox active under catalytic conditions; 
instead, the mechanism proceeds via direct addition of O2 to the metal-bound substrate dianion.206 Thus, the Fe- 
and Ni-ARDs are examples of substrate activation by a metalloenzyme, not O2 activation. It has been proposed 
that the unique regioselectivity of the ARDs is due to distinct coordination modes of acireductone to the Fe(II) 
and Ni(II) centers (the so-called “chelate hypothesis”).206,207 The chelate hypothesis, however, is not supported 
by biomimetic studies. The Berreau group has prepared synthetic models of the Fe- and Ni-ARD active sites that 
exhibit metal-dependent regioselectivity similar to that of the enzymes, even though the acireductone ligand 
adopts the same coordination mode in the Fe and Ni complexes.208,209,210,211,212,213,214,215 Mechanistic studies 
indicated that the Fe- and Ni-ARD models react with O2 to generate a common triketone intermediate, and it is 
the subsequent reactivity of this triketone with the metal complexes and H2O that accounts for the observed 
regioselectivity. The chelate hypothesis has also been called into question by computational studies of the Fe- 
and Ni-ARD mechanisms.216 
  
Scheme 6 Reactions catalyzed by Ni- and Fe-containing ARD 
Conclusions 
Collectively, the studies discussed in this review highlight the relative capabilities of mononuclear Mn, Co, and Ni 
centers to activate O2 in both enzymatic and synthetic environments. There are close parallels between the O2 
reaction pathways employed by manganese- and iron-containing systems. Both metals are able to access 
oxidation states between +2 and +5 under turnover conditions, permitting the formation of high-valent 
oxometal intermediates stable enough for spectroscopic and/or crystallographic characterization. However, as 
noted above, none of the mononuclear oxomanganese(IV) complexes in the literature have been prepared via 
direct reaction of a Mn(II) center with O2. The primary obstacle in the Mn(II) + O2 → Mn(IV)=O reaction appears 
to be the O–O bond homolysis step. In contrast to iron-based chemistry, there are no reported examples of 
mononuclear Mn(III)-OOR complexes (R = vacant, H, or alkyl) converting to an observable oxomanganese(IV) 
species. Instead, O–O homolysis generally requires a second metal center, resulting in dinuclear bis(μ-oxo) 
structures (Scheme 1). Because of this, high-valent oxomanganese species in O2-activating enzymes are only 
found in dinuclear active sites like ribonucleotide reductase, whereas mononuclear oxygenases involving an 
oxometal(IV) intermediate employ iron exclusively. 
The O2 activating potential of mononuclear Co(II) and Ni(II) centers is limited by the inability of these ions to 
access the +4 oxidation state and stabilize terminal oxide ligands. Thus, it is not surprising that all known O2-
activating enzymes containing Co or Ni employ mechanisms, such as those shown in Schemes 4 and 5, that do 
not require formation of a high-valent, oxometal intermediate. Instead, the divalent metal ions in ECDO and 
QDO simply serve as conduits of electron density between the activated substrate and O2. Nevertheless, 
synthetic Co and Ni complexes have displayed rich O2 chemistry that surpasses the narrow reactivity of these 
metals in biological systems. For example, numerous mononuclear superoxo- and peroxo-cobalt(III) species have 
been generated via reaction of O2 with Co(II) and Co(I) complexes. These Co/O2 adducts react with a second 
cobalt equivalent to afford dinuclear [Co 2 3+ (μ-O)2] units (Scheme 2). Because Ni(II) centers exhibit a low affinity 
for O2 unless supported by highly anionic chelates, recent Ni/O2 chemistry has successfully employed Ni(I) 
precursors to generate superoxo-nickel(II) and dinickel(III) species (Fig. 7). Future synthetic efforts will 
undoubtedly expand the boundaries of O2 chemistry for Mn, Co, and Ni complexes, and biochemists will 
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